AAAAAA

   
Results: 1-18 |
Results: 18
POSTCONFLUENT MULTILAYERED CELL-LINE CULTURES FOR SELECTIVE SCREENINGOF GEMCITABINE
Authors: SMITSKAMPWILMS E PINEDO HM VEERMAN G VANHAPEREN VWTR PETERS GJ
Citation: E. Smitskampwilms et al., POSTCONFLUENT MULTILAYERED CELL-LINE CULTURES FOR SELECTIVE SCREENINGOF GEMCITABINE, European journal of cancer, 34(6), 1998, pp. 921-926
SYNERGISTIC INTERACTION BETWEEN CISPLATIN AND GEMCITABINE IN-VITRO
Authors: BERGMAN AM VANHAPEREN VWTR VEERMAN G KUIPER CM PETERS GJ
Citation: Am. Bergman et al., SYNERGISTIC INTERACTION BETWEEN CISPLATIN AND GEMCITABINE IN-VITRO, Clinical cancer research, 2(3), 1996, pp. 521-530
ANTITUMOR-ACTIVITY OF PROLONGED AS COMPARED WITH BOLUS ADMINISTRATIONOF 2',2'-DIFLUORODEOXYCYTIDINE IN-VIVO AGAINST MURINE COLON TUMORS
Authors: VEERMAN G VANHAPEREN VWTR VERMORKEN JB NOORDHUIS P BRAAKHUIS BJM PINEDO HM PETERS GJ
Citation: G. Veerman et al., ANTITUMOR-ACTIVITY OF PROLONGED AS COMPARED WITH BOLUS ADMINISTRATIONOF 2',2'-DIFLUORODEOXYCYTIDINE IN-VIVO AGAINST MURINE COLON TUMORS, Cancer chemotherapy and pharmacology, 38(4), 1996, pp. 335-342
PRECLINICAL COMBINATION THERAPY WITH GEMCITABINE AND MECHANISMS OF RESISTANCE
Authors: PETERS GJ VANHAPEREN VWTR BERGMAN AM VEERMAN G SMITSKAMPWILMS E VANMOORSEL CJA KUIPER CM BRAAKHUIS BJM
Citation: Gj. Peters et al., PRECLINICAL COMBINATION THERAPY WITH GEMCITABINE AND MECHANISMS OF RESISTANCE, Seminars in oncology, 23(5), 1996, pp. 16-24
REGULATION OF PHOSPHORYLATION OF DEOXYCYTIDINE AND 2',2'-DIFLUORODEOXYCYTIDINE (GEMCITABINE) - EFFECTS OF CYTIDINE 5'-TRIPHOSPHATE AND URIDINE 5'-TRIPHOSPHATE IN RELATION TO CHEMOSENSITIVITY FOR 2',2'-DIFLUORODEOXYCYTIDINE
Authors: VANHAPEREN VWTR VEERMAN G VERMORKEN JB PINEDO HM PETERS GJ
Citation: Vwtr. Vanhaperen et al., REGULATION OF PHOSPHORYLATION OF DEOXYCYTIDINE AND 2',2'-DIFLUORODEOXYCYTIDINE (GEMCITABINE) - EFFECTS OF CYTIDINE 5'-TRIPHOSPHATE AND URIDINE 5'-TRIPHOSPHATE IN RELATION TO CHEMOSENSITIVITY FOR 2',2'-DIFLUORODEOXYCYTIDINE, Biochemical pharmacology, 51(7), 1996, pp. 911-918
SCHEDULE-DEPENDENT THERAPEUTIC EFFICACY OF THE COMBINATION OF GEMCITABINE AND CISPLATIN IN HEAD AND NECK-CANCER XENOGRAFTS
Authors: BRAAKHUIS BJM VANHAPEREN VWTR WELTERS MJP PETERS GJ
Citation: Bjm. Braakhuis et al., SCHEDULE-DEPENDENT THERAPEUTIC EFFICACY OF THE COMBINATION OF GEMCITABINE AND CISPLATIN IN HEAD AND NECK-CANCER XENOGRAFTS, European journal of cancer, 31A(13-14), 1995, pp. 2335-2340
3-DIMENSIONAL CELL-CULTURES AS A MODEL SYSTEM TO EVALUATE THE BIOLOGICAL-ACTIVITY OF GEMCITABINE (2',2'-DIFLUORO-2'DEOXYCYTIDINE)
Authors: PETERS GJ SMITSKAMPWILMS E VEERMAN G PIZAO PE VANHAPEREN VWTR PINEDO HM
Citation: Gj. Peters et al., 3-DIMENSIONAL CELL-CULTURES AS A MODEL SYSTEM TO EVALUATE THE BIOLOGICAL-ACTIVITY OF GEMCITABINE (2',2'-DIFLUORO-2'DEOXYCYTIDINE), Nucleosides & nucleotides, 14(3-5), 1995, pp. 661-664
PRECLINICAL STUDIES WITH NEW PYRROLIDINE PLATINUM(II) COMPOUNDS
Authors: SAMPEDRO F VANHAPEREN VWTR IZQUIERDO MA VICENS M SANTALO P PUEYO M LLAGOSTERA M MARCUELLO E DEANDRES L
Citation: F. Sampedro et al., PRECLINICAL STUDIES WITH NEW PYRROLIDINE PLATINUM(II) COMPOUNDS, European journal of medicinal chemistry, 30(6), 1995, pp. 497-501
INDUCTION OF RESISTANCE TO 2',2'-DIFLUORODEOXYCYTIDINE IN THE HUMAN OVARIAN-CANCER CELL-LINE A2780
Authors: VANHAPEREN VWTR VEERMAN G ERIKSSON S STEGMANN APA PETERS GJ
Citation: Vwtr. Vanhaperen et al., INDUCTION OF RESISTANCE TO 2',2'-DIFLUORODEOXYCYTIDINE IN THE HUMAN OVARIAN-CANCER CELL-LINE A2780, Seminars in oncology, 22(4), 1995, pp. 35-41
SCHEDULE-DEPENDENT ANTITUMOR EFFECT OF GEMCITABINE IN IN-VIVO MODEL SYSTEMS
Authors: BRAAKHUIS BJM VANHAPEREN VWTR BOVEN E VEERMAN G PETERS GJ
Citation: Bjm. Braakhuis et al., SCHEDULE-DEPENDENT ANTITUMOR EFFECT OF GEMCITABINE IN IN-VIVO MODEL SYSTEMS, Seminars in oncology, 22(4), 1995, pp. 42-46
INTERACTION BETWEEN CISPLATIN AND GEMCITABINE IN-VITRO AND IN-VIVO
Authors: PETERS GJ BERGMAN AM VANHAPEREN VWTR VEERMAN G KUIPER CM BRAAKHUIS BJM
Citation: Gj. Peters et al., INTERACTION BETWEEN CISPLATIN AND GEMCITABINE IN-VITRO AND IN-VIVO, Seminars in oncology, 22(4), 1995, pp. 72-79
TRANSFECTION OF WILD-TYPE DEOXYCYTIDINE KINASE (DCK) CDNA INTO AN ARAC-RESISTANT AND DAC-RESISTANT RAT LEUKEMIC-CELL LINE OF CLONAL ORIGIN FULLY RESTORES DRUG-SENSITIVITY
Authors: STEGMANN APA HONDERS WH WILLEMZE R VANHAPEREN VWTR LANDEGENT JE
Citation: Apa. Stegmann et al., TRANSFECTION OF WILD-TYPE DEOXYCYTIDINE KINASE (DCK) CDNA INTO AN ARAC-RESISTANT AND DAC-RESISTANT RAT LEUKEMIC-CELL LINE OF CLONAL ORIGIN FULLY RESTORES DRUG-SENSITIVITY, Blood, 85(5), 1995, pp. 1188-1194
NEW TARGETS FOR PYRIMIDINE ANTIMETABOLITES IN THE TREATMENT OF SOLID TUMORS .2. DEOXYCYTIDINE KINASE (VOL 16, PG 104, 1994)
Authors: VANHAPEREN VWTR PETERS GJ
Citation: Vwtr. Vanhaperen et Gj. Peters, NEW TARGETS FOR PYRIMIDINE ANTIMETABOLITES IN THE TREATMENT OF SOLID TUMORS .2. DEOXYCYTIDINE KINASE (VOL 16, PG 104, 1994), Pharmacy world & science, 16(3), 1994, pp. 168-168
NEW TARGETS FOR PYRIMIDINE ANTIMETABOLITES IN THE TREATMENT OF SOLID TUMORS .2. DEOXYCYTIDINE KINASE
Authors: VANHAPEREN VWTR PETERS GJ
Citation: Vwtr. Vanhaperen et Gj. Peters, NEW TARGETS FOR PYRIMIDINE ANTIMETABOLITES IN THE TREATMENT OF SOLID TUMORS .2. DEOXYCYTIDINE KINASE, Pharmacy world & science, 16(2), 1994, pp. 104-112
DEVELOPMENT AND MOLECULAR CHARACTERIZATION OF A 2',2'-DIFLUORODEOXYCYTIDINERESISTANT VARIANT OF THE HUMAN OVARIAN-CARCINOMA CELL-LINE A2780
Authors: VANHAPEREN VWTR VEERMAN G ERIKSSON S BOVEN E STEGMANN APA HERMSEN M VERMORKEN JB PINEDO HM PETERS GJ
Citation: Vwtr. Vanhaperen et al., DEVELOPMENT AND MOLECULAR CHARACTERIZATION OF A 2',2'-DIFLUORODEOXYCYTIDINERESISTANT VARIANT OF THE HUMAN OVARIAN-CARCINOMA CELL-LINE A2780, Cancer research, 54(15), 1994, pp. 4138-4143
SCHEDULE DEPENDENCE OF SENSITIVITY TO 2',2'-DIFLUORODEOXYCYTIDINE (GEMCITABINE) IN RELATION TO ACCUMULATION AND RETENTION OF ITS TRIPHOSPHATE IN SOLID TUMOR-CELL LINES AND SOLID TUMORS
Authors: VANHAPEREN VWTR VEERMAN G BOVEN E NOORDHUIS P VERMORKEN JB PETERS GJ
Citation: Vwtr. Vanhaperen et al., SCHEDULE DEPENDENCE OF SENSITIVITY TO 2',2'-DIFLUORODEOXYCYTIDINE (GEMCITABINE) IN RELATION TO ACCUMULATION AND RETENTION OF ITS TRIPHOSPHATE IN SOLID TUMOR-CELL LINES AND SOLID TUMORS, Biochemical pharmacology, 48(7), 1994, pp. 1327-1339
DEOXYCYTIDINE KINASE AND DEOXYCYTIDINE DEAMINASE ACTIVITIES IN HUMAN TUMOR XENOGRAFTS
Authors: VANHAPEREN VWTR VEERMAN G BRAAKHUIS BJM VERMORKEN JB BOVEN E LEYVA A PETERS GJ
Citation: Vwtr. Vanhaperen et al., DEOXYCYTIDINE KINASE AND DEOXYCYTIDINE DEAMINASE ACTIVITIES IN HUMAN TUMOR XENOGRAFTS, European journal of cancer, 29A(15), 1993, pp. 2132-2137
2',2'-DIFLUORO-DEOXYCYTIDINE (GEMCITABINE) INCORPORATION INTO RNA ANDDNA OF TUMOR-CELL LINES
Authors: VANHAPEREN VWTR VEERMAN G VERMORKEN JB PETERS GJ
Citation: Vwtr. Vanhaperen et al., 2',2'-DIFLUORO-DEOXYCYTIDINE (GEMCITABINE) INCORPORATION INTO RNA ANDDNA OF TUMOR-CELL LINES, Biochemical pharmacology, 46(4), 1993, pp. 762-766
Risultati: 1-18 |